Patient basic information Patient: Ms. Nicole Thompson) Nationality: Ireland Diagnosis: retinal detachment Clinical hospital: H0O treatment: targeted treatment + immunotherapy Accommodation days: 94 days Treatment cost: about 355388 yuan Treatment effect: complete alleviation Describes the condition Ms. Nicole comes from Ireland, where she was diagnosed with retinal detachment.
Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, guidance and on-site services throughout the treatment process. The MD2 team used a comprehensive set of targeted therapeutic+immunotherapies, with the medical team closely monitoring the patient's indicators and dynamic adjustment programs during the treatment process. After 94 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the hospital standard.
The patient's treatment resulted in complete relief. When the patient was released, the medical team developed a detailed return follow-up and rehabilitation plan for him, and continued to monitor the recovery through the remote follow-up system. The patient commented, 'The level of expertise of Chinese doctors and the condition of the equipment in Chinese hospitals impressed us that every link from the ground to the hospital was arranged with a well.
'Mrs. Nicole, experts have criticized the case as a typical case of cross-border suspected seriousness clinical cases. M4A relies on multidisciplinary collaborative mechanisms to develop targeted therapeutic+immunotherapy programs for retinal detachment, reflecting the comprehensive strength of Chinese hospitals in the field of suspected disease diagnostics and a summary of how international medical services are regulated.